Results 161 to 170 of about 14,017 (290)

Evolving health policy and regulatory oversight of medicinal cannabis in Australia: lessons for sustainable integration. [PDF]

J Cannabis Res
Lim ECN, Lim CED.
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

The association between sleep disturbance and stimulant use: A cross‐lagged examination

Addiction, EarlyView.
Abstract Background and aims Sleep disruptions increase the risk of substance misuse. Substance use—especially stimulants—can increase acute and chronic sleep dysfunction. This study aimed to estimate the associations between sleep disturbance and stimulant use over time among participants with stimulant use disorder (StUD).
Viviana E. Horigian, Renae D. Schmidt, Daniel J. Feaster, Rui Duan, Sophia T. Gonzalez, Kathryn Hefner, Dikla Shmueli‐Blumberg, Ashley Vena, Landhing M. Moran, Chloe A. DiCamillo, Shirin Shafazand, Susan Tross, Judith Feinberg   +12 more
wiley   +1 more source

Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines. [PDF]

Pharmaceuticals (Basel)
Vitetta L, Henson JD, Hayes E, Rutolo D, Hall S.   +4 more
europepmc   +1 more source

Officials travel abroad to help sort out Ireland's problem in sourcing medicinal cannabis.

, 2018
The government is finding it difficult to find a quality assured supplier of cannabis and a supplier that can export its products to Ireland....
Finn, Christina
core  

The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Prescription opioid‐related harm remains a significant public health concern. This study aimed to evaluate the efficacy of the Opioid Safety Toolkit, a co‐designed, interactive online resource, in increasing naloxone uptake and healthcare provider discussions among adults prescribed opioids for pain.
Suzanne Nielsen, Frederick Fox, Tina Lam, Alex Waddell, Monica Jung, Bosco Rowland, Jessica Watterson, Dhruv Basur, Chris Prawira, Joshua Paolo Seguin, Patrick Olivier, Jarrod McMaugh, Paul Dietze, Louisa Picco   +13 more
wiley   +1 more source

Medicinal cannabis: is current use clinically justified? [PDF]

Intern Med J
Scott RJ, Scott IA.
europepmc   +1 more source

Accessing illicit medicines : the search for medicinal cannabis in Flanders

, 2019
Introduction: The Belgian legislation on cannabis still prohibits its use, sale and possession. No approval for medicinal use exists, except for the cannabis-based medicine Sativex. Therefore, current policy limits the sources of supply patients can rely
Bawin, Frédérique, Bawin, FrédériqueRE2300010034185080200207765429524180-F0EE-11E1-A9DE-61C894A0A6B4   +1 more
core  

The evolution of Australian cannabis policies, 1967 to 2024

Addiction, EarlyView.
Abstract Aim To describe the outcomes of cannabis policy debates in Australia from 1967 to 2024. Methods We searched popular media, public reports, parliamentary inquiries and policy documents on cannabis in Australia since the 1960s and examined peer reviewed papers, national survey data and police records of cannabis‐related arrests.
Wayne D. Hall, Danielle Dawson, Ben Johnson, Tesfa M. Yimer   +3 more
wiley   +1 more source

Medicinal cannabis for tics in adolescents with Tourette syndrome. [PDF]

BJPsych Open
Eapen V, Lin PI, Taylor K, Chan E, Chay P, Cranswick N, Ka A, Khan F, Payne JM, Prakash C, Velalagan R, Efron D.   +11 more
europepmc   +1 more source